Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

This large-scale exploratory study demonstrated that the prevalence of HDV antibody positivity was very low (0.24%) in Chinese patients with chronic ... patients were hepatitis B e antigen-positive.

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

Among those who may need a hep B booster are people on dialysis in whom the protective antibodies ... Avoiding hepatitis B also helps you steer clear of complications of a chronic infection.

Arbutus Biopharma Corporation (Nasdaq: ABUS) announced the acceptance of five abstracts, including a late-breaking study, for ...

Despite numerous treatment advances, chronic hepatitis B virus (HBV) infection remains a largely incurable disease impacting more than 290 million people worldwide. All patients with chronic HBV ...

An estimated 460 Australians died from complications from chronic hepatitis ... Tran’s two children received hepatitis B immunisations and injections of antibodies at birth to ensure they ...

The researchers followed 191 healthy, vaginally born infants from their birth to 15 months: 86% of the participants received the hepatitis B ... antibodies by linking the polysaccharide capsule ...